Status:
COMPLETED
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
Lead Sponsor:
Vistakon Pharmaceuticals
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety of a novel contact lens in healthy normal volunteers.
Eligibility Criteria
Inclusion
- healthy normal, soft contact lens wearing volunteers
- normal ocular health
- contact lens correction from +6.00 to -12.00D in each eye and astigmatism of -1.00D or less in each eye
Exclusion
- active ocular infection
- history of ocular surgery
- use of topical ophthalmic preparations (including rewetting drops)
- pregnancy or lactation
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00889252
Start Date
April 1 2009
Last Update
March 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memphis, Tennessee, United States